Valuation — not yet established
No valuation for Oncopia Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($8.4M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Oncopia Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2020 | Buyout/LBO (Add-on)† | — | ▮ | ▮ |
| Dec 2018 | Seed Round | $1.5M | ▮ | ▮ |
| Oct 2018 | Seed Round | $4.4M | ▮ | ▮ |
| Dec 2017 | Seed Round | $2.5M | ▮ | ▮ |
How Oncopia Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Oncopia Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Oncopia Therapeutics raised?
- Oncopia Therapeutics has raised $8.4M in total funding across 4 recorded rounds.
- When did Oncopia Therapeutics last raise?
- Oncopia Therapeutics last raised in Dec 2020 (Buyout/LBO (Add-on)†).